UM  > 中華醫藥研究院
Obstacles and opportunities in Chinese pharmaceutical innovation
Ni J.; Zhao J.; Ung C.O.L.; Hu Y.; Hu H.; Wang Y.
2017-03-24
Source PublicationGlobalization and Health
ISSN17448603
Volume13Issue:1Pages:21
Abstract

Background: Global healthcare innovation networks nowadays have expanded beyond developed countries with many developing countries joining the force and becoming important players. China, in particular, has seen a significant increase in the number of innovative firms and research organizations stepping up to the global network in recent years. Nevertheless, the intense Research and Development input has not brought about the expectable output. While China is ascending at a great speed to a leading position worldwide in terms of Research and Development investment, scientific publications and patents, the innovation capabilities in the pharmaceutical sector remain weak. Discussion: This study discusses the challenges and opportunities for pharmaceutical innovation in China. One hand, academic, industrial, institutional and financial constraints were found to be the major and inevitable barriers hindering the development of drug innovation. On the other hand, unique advantages had been observed which included growing pharmaceutical market, Research and Development funding, distinctive source, and international cooperation. Summary: The most important thing for China's pharmaceutical sector to leap forward is to break though innovation barriers and integrate own advantages into global value-chain of healthcare product development.

KeywordChina Global Network Innovation Obstacles Opportunities Pharmaceutical Industry
DOIhttp://doi.org/10.1186/s12992-017-0244-6
URLView the original
Indexed BySCI
Language英语
WOS Research AreaPublic, Environmental & Occupational Health
WOS SubjectPublic, Environmental & Occupational Health
WOS IDWOS:000397732800001
Fulltext Access
Citation statistics
Cited Times [WOS]:5   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionInstitute of Chinese Medical Sciences
Corresponding AuthorHu Y.
AffiliationInstitute of Chinese Medical Sciences, State Key Laboratory of Quality Research in Chinese Medicine, University of Macau, Room 2053, N22, Avenida da Universidade, Taipa, Macau, China
First Author AffilicationInstitute of Chinese Medical Sciences
Corresponding Author AffilicationInstitute of Chinese Medical Sciences
Recommended Citation
GB/T 7714
Ni J.,Zhao J.,Ung C.O.L.,et al. Obstacles and opportunities in Chinese pharmaceutical innovation[J]. Globalization and Health,2017,13(1):21.
APA Ni J.,Zhao J.,Ung C.O.L.,Hu Y.,Hu H.,&Wang Y..(2017).Obstacles and opportunities in Chinese pharmaceutical innovation.Globalization and Health,13(1),21.
MLA Ni J.,et al."Obstacles and opportunities in Chinese pharmaceutical innovation".Globalization and Health 13.1(2017):21.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Ni J.]'s Articles
[Zhao J.]'s Articles
[Ung C.O.L.]'s Articles
Baidu academic
Similar articles in Baidu academic
[Ni J.]'s Articles
[Zhao J.]'s Articles
[Ung C.O.L.]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Ni J.]'s Articles
[Zhao J.]'s Articles
[Ung C.O.L.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.